Skip to main content
Premium Trial:

Request an Annual Quote

IBM, NetGenics Partner in Deploying DiscoveryLink

Premium

WHITE PLAINS, NY--IBM announced that it has launched DiscoveryLink, a combination of middleware and integration services that it said will speed product cycles and reduce development costs for agriscience, biotechnology, and pharmaceutical companies. DiscoveryLink is the first product of IBM’s newly formed life sciences organization.

To deploy the product, IBM will team with software provider NetGenics of Cleveland, Ohio. Daniel McCurdy, vice-president, IBM life sciences, said, "By combining our expertise in database and IT infrastructure with NetGenics’ knowledge of industry applications, we can deliver a solution that we expect will dramatically impact the industry’s productivity."

IBM said the package, which will be available first quarter 2000, will create a virtual database by allowing data to be accessed by an application program as if they were in a single database, and in a single format, even though they remain heterogeneous in format and decentralized.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.